BIOVAXYS TECHNOLOGY RSS Feed | Nachrichten - www.finanzen.netwww.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHFri, 03 Apr 2026 22:05:24 +0200https://images.finanzen.net/images/finanzen_net_neu.gifBIOVAXYS TECHNOLOGY RSS Feed | Nachrichten - www.finanzen.nethttps://www.finanzen.netBIOVAXYS ANNOUNCES UPSIZING OF LIFE OFFERING OF UP TO $2MThu, 30 Oct 2025 21:57:00 +0100https://www.finanzen.net/nachricht/aktien/biovaxys-announces-upsizing-of-life-offering-of-up-to-2m-15151186

// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES //

]]>https://www.finanzen.net/nachricht/aktien/biovaxys-announces-upsizing-of-life-offering-of-up-to-2m-15151186BIOVAXYS ANNOUNCES UPSIZING OF LIFE OFFERING OF UP TO $2MThu, 30 Oct 2025 21:54:00 +0100https://www.finanzen.net/nachricht/aktien/biovaxys-announces-upsizing-of-life-offering-of-up-to-2m-15151185

// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES //

]]>https://www.finanzen.net/nachricht/aktien/biovaxys-announces-upsizing-of-life-offering-of-up-to-2m-15151185BIOVAXYS ANNOUNCES CONVERSION OF DEBENTURESTue, 28 Oct 2025 12:00:00 +0100https://www.finanzen.net/nachricht/aktien/biovaxys-announces-conversion-of-debentures-15131208

// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES //

]]>https://www.finanzen.net/nachricht/aktien/biovaxys-announces-conversion-of-debentures-15131208BIOVAXYS ANNOUNCES CONVERSION OF DEBENTURESTue, 28 Oct 2025 12:00:00 +0100https://www.finanzen.net/nachricht/aktien/biovaxys-announces-conversion-of-debentures-15131233

// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES //

]]>https://www.finanzen.net/nachricht/aktien/biovaxys-announces-conversion-of-debentures-15131233BIOVAXYS ANNOUNCES CONVERSION OF DEBENTURESWed, 22 Oct 2025 09:47:00 +0200https://www.finanzen.net/nachricht/aktien/biovaxys-announces-conversion-of-debentures-15105319

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

]]>https://www.finanzen.net/nachricht/aktien/biovaxys-announces-conversion-of-debentures-15105319BIOVAXYS ANNOUNCES CONVERSION OF DEBENTURESWed, 22 Oct 2025 09:45:00 +0200https://www.finanzen.net/nachricht/aktien/biovaxys-announces-conversion-of-debentures-15105297

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

]]>https://www.finanzen.net/nachricht/aktien/biovaxys-announces-conversion-of-debentures-15105297BIOVAXYS ANNOUNCES CONVERSION OF DEBENTURES AND GRANT OF STOCK OPTIONSTue, 21 Oct 2025 01:40:00 +0200https://www.finanzen.net/nachricht/aktien/biovaxys-announces-conversion-of-debentures-and-grant-of-stock-options-15099110

// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES //

]]>https://www.finanzen.net/nachricht/aktien/biovaxys-announces-conversion-of-debentures-and-grant-of-stock-options-15099110BIOVAXYS ANNOUNCES CONVERSION OF DEBENTURES AND GRANT OF STOCK OPTIONSTue, 21 Oct 2025 01:39:00 +0200https://www.finanzen.net/nachricht/aktien/biovaxys-announces-conversion-of-debentures-and-grant-of-stock-options-15099109

// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES //

]]>https://www.finanzen.net/nachricht/aktien/biovaxys-announces-conversion-of-debentures-and-grant-of-stock-options-15099109BioVaxys Licensee SpayVac-for-Wildlife, Inc., Reports Further Positive Single-Dose Efficacy Data for Its Immunocontraceptive Vaccine and Initiation of Regulatory Submission ProcessTue, 14 Oct 2025 14:00:00 +0200https://www.finanzen.net/nachricht/aktien/biovaxys-licensee-spayvac-for-wildlife-inc-reports-further-positive-single-dose-efficacy-data-for-its-immunocontraceptive-vaccine-and-initiation-of-regulatory-submission-process-15044650

VANCOUVER, BC and MADISON, Wis., Oct. 14, 2025 /CNW/ -- BioVaxys Technology ...

]]>https://www.finanzen.net/nachricht/aktien/biovaxys-licensee-spayvac-for-wildlife-inc-reports-further-positive-single-dose-efficacy-data-for-its-immunocontraceptive-vaccine-and-initiation-of-regulatory-submission-process-15044650BioVaxys Licensee SpayVac-for-Wildlife, Inc., Reports Further Positive Single-Dose Efficacy Data for Its Immunocontraceptive Vaccine and Initiation of Regulatory Submission ProcessTue, 14 Oct 2025 14:00:00 +0200https://www.finanzen.net/nachricht/aktien/biovaxys-licensee-spayvac-for-wildlife-inc-reports-further-positive-single-dose-efficacy-data-for-its-immunocontraceptive-vaccine-and-initiation-of-regulatory-submission-process-15044786

VANCOUVER, BC and MADISON, Wis., Oct. 14, 2025 /PRNewswire/ -- BioVaxys Technology ...

]]>https://www.finanzen.net/nachricht/aktien/biovaxys-licensee-spayvac-for-wildlife-inc-reports-further-positive-single-dose-efficacy-data-for-its-immunocontraceptive-vaccine-and-initiation-of-regulatory-submission-process-15044786